RXRX vs PRGS

Comparison between Recursion Pharmaceuticals Inc - Class A (RXRX, Company) and Progress Software Corp (PRGS, Company).

RXRX is from the Healthcare sector, while PRGS is from the Technology sector.

5-Year PerformancePRGS has outperformed RXRX, delivering a return of -3.1% compared to -39.0%

RXRX vs PRGS - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	RXRX(COMPANY)	PRGS(COMPANY)
Market Cap	$1.58B	$1.57B
Max Drawdown	93.13%	64.10%
Sharpe Ratio	-0.82	-0.35
5Y Beta	2.62	0.64
Industry	Biotechnology	Software - Infrastructure
P/E Ratio	-2.58	17.94
Forward P/E	N/A	6.61
PEG Ratio	N/A	0.31
5Y Dividends CAGR	N/A	2.86%
5Y EPS CAGR	-10.03%	4.80%
Debt to Equity	0.00%	255.32%
Free Cash Flow Yield	-20.61%	19.49%
P/S Ratio	23.82	1.55
P/B Ratio	1.59	3.20

Market Cap

Winner

RXRX

$1.58B

PRGS

$1.57B

Max Drawdown

RXRX

93.13%

Winner

PRGS

64.10%

Sharpe Ratio

RXRX

-0.82

Winner

PRGS

-0.35

5Y Beta

RXRX

2.62

Winner

PRGS

0.64

Industry

RXRX

Biotechnology

PRGS

Software - Infrastructure

P/E Ratio

Winner

RXRX

-2.58

PRGS

17.94

Forward P/E

RXRX

N/A

PRGS

6.61

PEG Ratio

RXRX

N/A

PRGS

0.31

5Y Dividends CAGR

RXRX

N/A

PRGS

2.86%

5Y EPS CAGR

RXRX

-10.03%

Winner

PRGS

4.80%

Debt to Equity

Winner

RXRX

0.00%

PRGS

255.32%

Free Cash Flow Yield

RXRX

-20.61%

Winner

PRGS

19.49%

P/S Ratio

RXRX

23.82

Winner

PRGS

1.55

P/B Ratio

Winner

RXRX

1.59

PRGS

3.20

RXRX vs PRGS - Historical Returns

Returns include dividend reinvestment.

Period	RXRX	PRGS
1 month	-8.36%	+26.34%
3 months	-15.67%	+39.00%
6 months	-37.42%	-10.79%
1 year	-52.72%	-24.25%
5 years(CAGR)	-38.99%	-3.09%
10 years(CAGR)	N/A	+3.93%
Max(CAGR)	-36.08%	+5.16%

RXRX

-8.36%

Winner

PRGS

+26.34%

RXRX

-15.67%

Winner

PRGS

+39.00%

RXRX

-37.42%

Winner

PRGS

-10.79%

RXRX

-52.72%

Winner

PRGS

-24.25%

5Y(CAGR)

RXRX

-38.99%

Winner

PRGS

-3.09%

10Y(CAGR)

RXRX

N/A

PRGS

+3.93%

Max(CAGR)

RXRX

-36.08%

Winner

PRGS

+5.16%

RXRX vs PRGS - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	RXRX	PRGS
2026	-29.52%	-7.84%
2025	-43.27%	-33.61%
2024	-31.51%	+21.18%
2023	+30.60%	+7.83%
2022	-57.24%	+6.31%
2021	-45.27%	+10.18%
2020	N/A	+8.81%
2019	N/A	+19.53%
2018	N/A	-16.72%
2017	N/A	+34.92%
2016	N/A	+33.99%
2015	N/A	-10.25%
2014	N/A	+5.79%
2013	N/A	+19.92%
2012	N/A	+6.01%
2011	N/A	-32.87%
2010	N/A	+43.00%
2009	N/A	+47.06%
2008	N/A	-41.90%
2007	N/A	+19.73%
2006	N/A	-3.32%
2005	N/A	+21.80%
2004	N/A	+12.91%
2003	N/A	+55.47%
2002	N/A	-28.85%
2001	N/A	+25.67%
2000	N/A	-46.89%
1999	N/A	+70.01%

RXRX vs PRGS Drawdown Comparison

The maximum drawdown for RXRX was -93.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The maximum drawdown for PRGS was -64.10%, occurring on Apr 1, 2026. This drawdown has not yet recovered.

The current RXRX drawdown is -92.84%. The current PRGS drawdown is -45.84%.

Rank	RXRX	PRGS
#1	-93.13% Jul 13, 2021 - Mar 30, 2026	-64.10% Nov 25, 2024 - Apr 1, 2026
#2	-38.10% Apr 29, 2021 - Jun 17, 2021	-61.44% Dec 28, 1999 - Jun 16, 2005
#3	-10.54% Apr 16, 2021 - Apr 21, 2021	-56.52% Dec 26, 2007 - May 13, 2010
#4	-10.45% Jun 21, 2021 - Jul 6, 2021	-45.30% Feb 14, 2011 - Dec 8, 2016
#5	-8.29% Apr 21, 2021 - Apr 29, 2021	-41.33% Jan 17, 2018 - Sep 24, 2021
#6	N/A	-36.26% Sep 20, 2005 - May 31, 2007
#7	N/A	-22.51% May 13, 2010 - Oct 8, 2010
#8	N/A	-21.14% Nov 16, 2021 - Nov 15, 2022
#9	N/A	-21.02% Aug 29, 2023 - Sep 25, 2024
#10	N/A	-19.22% Jun 21, 2007 - Dec 6, 2007
#11	N/A	-14.70% Dec 27, 2016 - Jul 25, 2017
#12	N/A	-12.55% Dec 20, 1999 - Dec 28, 1999
#13	N/A	-12.48% Jun 14, 2023 - Aug 7, 2023
#14	N/A	-12.21% Dec 6, 1999 - Dec 15, 1999
#15	N/A	-9.11% Mar 3, 2023 - May 24, 2023